A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| FGFR3 (K650E), active, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. |  |
| FGFR4 (460-end), active, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?80% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| FGFR4-IN-1 | FGFR4-IN-1 is a potent and selective FGFR4 inhibitor with potential for the treatment of gastric cancer. Synonyms: N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((3-oxomorpholino)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide; FGFR4-IN-1; FGFR4-IN1; FGFR4-IN 1. CAS No. 1708971-72-5. Molecular formula: C24H27N7O5. Mole weight: 493.52. |  |
| FGFR4-IN-1 | FGFR4-IN-1 is a potent and selective FGFR4 inhibitor. FGFR4 may be a novel therapeutic target for gastric cancer. Uses: Designed for use in research and industrial production. Additional or Alternative Names: FGFR4-IN-1; FGFR4-IN1; FGFR4-IN 1. Product Category: Inhibitors. Appearance: Solid powder. CAS No. 1708971-72-5. Molecular formula: C24H27N7O5. Mole weight: 493.52. Purity: >98%. IUPACName: N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((3-oxomorpholino)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide. Canonical SMILES: O=C(N1CCCC2=CC(CN3C(COCC3)=O)=C(C=O)N=C12)NC4=NC=C(C#N)C(NCCOC)=C4. Product ID: ACM1708971725. Alfa Chemistry ISO 9001:2015 Certified. |  |
| FGF Receptor Tyrosine Kinase Inhibitor - CAS 192705-79-6 | The FGF Receptor Tyrosine Kinase Inhibitor, also referenced under CAS 192705-79-6, controls the biological activity of FGF Receptor Tyrosine Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| FGF Receptor Tyrosine Kinase Inhibitor IV, NP603 - CAS 949164-80-1 | The FGF Receptor Tyrosine Kinase Inhibitor IV, NP603 controls the biological activity of FGF Receptor Tyrosine KInase. Primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| FGFR-IN-1 | FGFR-IN-1 is a potent FGFR inhibitor with an IC 50 of <100 nM for FGFR1, FGFR2, and FGFR3, respectively (patent US20130338134A1, example 219) [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1513860-41-7. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-145043. |  |
| FGF/VEGF Receptor Tyrosine Kinase Inhibitor, PD173074 - CAS 219580-11-7 | The FGF/VEGF Receptor Tyrosine Kinase Inhibitor, PD173074 controls the biological activity of FGF/VEGF Receptor Tyrosine Kinase. Primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| FGH10019 | FGH10019 is a novel sterol regulatory element-binding protein (SREBP) inhibitor with IC50 of 1 μM, 5-10 times lower than the IC50 of fatostatin (~10 μM). Synonyms: FGH10019;FGH 10019; FGH-10019. Grades: >98%. CAS No. 1046045-61-7. Molecular formula: C18H19N3O2S2. Mole weight: 373.49. | |
| FGIN 1-27 | FGIN 1-27, an indoleacetamide, is a specific peripheral benzodiazepine receptor (PBR) ligand with a K i of 5.0 nM. FGIN 1-27 can penetrate the blood brain barrier (BBB). FGIN 1-27 inhibits the onset of Isoniazid-induced convulsions [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 142720-24-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-101059. | |
| FGIN-1-27 | FGIN-1-27. Group: Biochemicals. Grades: Purified. CAS No. 142720-24-9. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. |  Worldwide |
| FGIN-1-27 | FGIN-1-27 is a high affinity agonist of mitochondrial benzodiazepine receptors (PBR) binding to benzodiazepine receptors on mitochondrial membranes. FGIN-1-27 indirectly potentiates GABAA receptor signaling to exhibit anticonvulsant, anxiolytic, and sedative activity in both animal and clinical models. Synonyms: FGIN-1-27; FGIN 1 27; FGIN-1 27; FGIN 1-27; FGIN127; N,N-Dihexyl-2-(4-fluorophenyl)indole-3-acetamide; 2-[2-(4-fluorophenyl)-1H-indol-3-yl]-N,N-dihexylacetamide. Grades: ≥98% by HPLC. CAS No. 142720-24-9. Molecular formula: C28H37FN2O. Mole weight: 436.61. | |
| FGIN-1-43 | FGIN-1-43. Group: Biochemicals. Grades: Purified. CAS No. 145040-29-5. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| FGIN-1-43 | FGIN-1-43 is a potent and specific ligand for the mitochondial DBI receptor (MDR). Synonyms: FGIN-1-43; FGIN 1 43; FGIN 1-43; FGIN-1 43; FGIN143; N,N-Dihexyl-2-(4-chlorophenyl)-5-chloroindole-3-acetamide; 2-[5-chloro-2-(4-chlorophenyl)-1H-indol-3-yl]-N,N-dihexylacetamide. Grades: ≥98%. CAS No. 145040-29-5. Molecular formula: C28H36Cl2N2O. Mole weight: 487.51. | |
| FGR, active, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| FGTI-2734 | FGTI-2734 is a RAS C-terminal mimetic dual farnesyl transferase (FT) and geranylgeranyl transferase-1 (GGT-1) inhibitor. It can prevent membrane localization of KRAS, hence solving KRAS resistance problem and thwarting mutant KRAS patient-derived pancreatic tumors. Uses: Designed for use in research and industrial production. Additional or Alternative Names: FGTI-2734; FGTI2734; FGTI 2734. Product Category: Inhibitors. Appearance: Solid powder. CAS No. 1247018-19-4. Molecular formula: C26H31FN6O2S. Mole weight: 510.63. Purity: >98%. IUPACName: N-(2-((4-cyano-2-fluorophenyl)((1-methyl-1H-imidazol-5-yl)methyl)amino)ethyl)-N-(cyclohexylmethyl)pyridine-2-sulfonamide. Canonical SMILES: O=S(C1=NC=CC=C1)(N(CC2CCCCC2)CCN(CC3=CN=CN3C)C4=CC=C(C=C4F)C#N)=O. Product ID: ACM1247018194. Alfa Chemistry ISO 9001:2015 Certified. | |
| FH1 | FH1 (NSC 12407) enhances hepatocyte functions, and promotes the differentiation of induced pluripotent stem (iPS)-derived hepatocytes toward a phenotype more mature and the maturation of well-differentiated cultures of hepatocyte-like cells (iHeps) [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: NSC 12407; BRD-K4477. CAS No. 2719-5-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-12346. | |
| FH1 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| FH 1 | FH 1. Group: Biochemicals. Grades: Purified. CAS No. 2719-5-3. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| FH535 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| FH535 | FH535 is a Wnt/β-catenin signaling inhibitor. It was shown to inhibit proliferation and motility of various cancer stem cells including liver cancer stem cells and colon cancer cells. Synonyms: 2,5-dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide. Grades: >98%. CAS No. 108409-83-2. Molecular formula: C13H10Cl2N2O4S. Mole weight: 361.20. | |
| FH 535 | FH 535. Group: Biochemicals. Grades: Purified. CAS No. 108409-83-2. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| FH535 sodium salt | FH535 sodium salt is a dual inhibitor of peroxisome proliferator-activated receptor (PPAR) and Wnt/β-catenin/TCF/LEF signaling. FH535 inhibits recruitment of the coactivators β-catenin and GRIP1. FH535 is selectively toxic to carcinomas expressing the Wnt/β-Catenin pathway, leading to the inhibition of proliferation and motility of multiple cancer cells. Synonyms: FH535 sodium salt; FH 535 sodium salt; FH-535 sodium salt; (2,5-dichlorophenyl)sulfonyl-(2-methyl-4-nitrophenyl)azanide sodium salt. Grades: 99%. Molecular formula: C13H9Cl2N2NaO4S. Mole weight: 383.18. | |
| FHD-609 | FHD-609 is a PROTAC degrader and inhibitor of BRD9 ( Bromodomain-containing protein 9 ). FHD-609 targets to ncBAF , can be used for research of wide range of cancers that contain a mutation in a BAF complex subunit. FHD-609 in combination with Telomelysin or INO5401, may play a role in adrenocortical carcinoma (ACC) treatment. (Blue: BRD9 ligand-6 (HY-49393), Black: linker (HY-168309); Pink: (S)-Deoxy-thalidomide-Br (HY-168308) ) [1] [2] [3] [4] [5]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2676211-64-4. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-153367. | |
| FHN88734 | FHN88734, also known as Z-Asp-CH2-DCB and PASE-1 INHIBITOR V, is an inhibitor of ICE/Ced-3 family proteases. This product has no formal name at the moment. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Z-Asp-CH2-DCB; PASE-1 INHIBITOR V; FHN88734; FHN-88734; FHN 88734. Product Category: Inhibitors. Appearance: To be determined. CAS No. 153088-73-4. Molecular formula: C20H17Cl2NO7. Mole weight: 454.26. Purity: >98%. IUPACName: (S)-3-(((benzyloxy)carbonyl)amino)-5-((2,6-dichlorobenzoyl)oxy)-4-oxopentanoic acid. Canonical SMILES: ClC1=C(C(OCC([C@@H](NC(OCC2=CC=CC=C2)=O)CC(O)=O)=O)=O)C(Cl)=CC=C1. Product ID: ACM153088734-1. Alfa Chemistry ISO 9001:2015 Certified. | |
| FHT-2344 | FHT-2344 is a SMARCA4/SMARCA2 ATPase inhibitor with IC 50 values of 0.026 μM and 0.013 μM, respectively. FHT-2344 has anticancer activity [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2468058-90-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-149458. | |
| FHV Coat-(35-49) | It is a peptide extracted from the flock house virus (FHV) coat protein and internalized with maximum efficiency into Chinese hamster ovary (CHO-K1), HeLa, and Jurkat cells. Synonyms: H-Arg-Arg-Arg-Arg-Asn-Arg-Thr-Arg-Arg-Asn-Arg-Arg-Arg-Val-Arg-OH; L-arginyl-L-arginyl-L-arginyl-L-arginyl-L-asparagyl-L-arginyl-L-threonyl-L-arginyl-L-arginyl-L-asparagyl-L-arginyl-L-arginyl-L-arginyl-L-valyl-L-arginine. Grades: ≥95%. Molecular formula: C83H162N50O19. Mole weight: 2164.54. | |
| FHZ | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| FI-700 | FI-700 is a novel and potent FLT3 inhibitor with promising antileukemia activity. FI-700 showed a potent IC(50) value against FLT3 kinase at 20 nmol/L in an in vitro kinase assay. FI-700 showed selective growth inhibition against mutant FLT3-expressing leukemia cell lines and primary acute myeloid leukemia cells, whereas it did not affect the FLT3 ligand (FL)-driven growth of Wt-FLT3-expressing cells. Oral administration of FI-700 induced the regression of tumors in a s.c. tumor xenograft model and increased the survival of mice in an i.v. transplanted model. Furthermore, FI-700 treatment eradicated FLT3/ITD-expressing leukemia cells, both in the peripheral blood and in the bone marrow. Synonyms: FI700; FI 700. CAS No. 866883-79-6. Molecular formula: C21H29N9O. Mole weight: 423.53. | |
| Fiacitabine | Fiacitabine is a selective inhibitior of DNA replication of herpes simplex virus(HSV). It was active at much lower concentrations than arabinosylcytosine, iododeoxyuridine, and arabinosyladenine. It was slightly more active against herpes simplex virus type 1 than acycloquanosine and slightly more toxic to normal cells. Uses: Antineoplastic agents. Synonyms: 1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodocytosine; 5-Iodo-2'-deoxy-2'-fluoro-beta-D-arabinocytidine; FICA; DRG-0077; DRG 0077; DRG0077; FOAC; Fluoroiodoaracytidine; Fluorviodoaracytidine; 4-Amino-1-((2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidin-2(1H)-one; 1-β-D-2'-Fluoroarabino-5-iodocytosine; 2'-Fluoro-5-iodo-1-β-D-arabinofuranosylcytosine; NSC 382097. Grades: ≥95%. CAS No. 69123-90-6. Molecular formula: C9H11FIN3O4. Mole weight: 371.10. | |
| Fialuridine | An antiviral agent; nucleoside analog with antihepatitis B activity. Group: Biochemicals. Alternative Names: 1-(2-Deoxy-2-fluoro- β-D-arabinofuranosyl)-5-iodo-. Grades: Highly Purified. CAS No. 69123-98-4. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Fialuridine | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopypharmaceutical toxicology. | |
| Fialuridine | Fialuridine (FIAU) is a thymidine-based nucleoside analog with antiviral activity. Fialuridine and its metabolites blocks DNA synthesis in human cytomegalovirus and hepatitis B, as well as herpes simplex. Uses: Antiviral agents. Synonyms: 5-Iodo-2'-deoxy-2'-fluoro-beta-D-arabinouridine; FIAU; Fluoroiodoarauracil; 5-Iodo-2'-Fluoroarauracil; NSC 678514; 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodo-2,4(1H,3H)-pyrimidinedione; 1-(2'-Deoxy-2'-fluoro-β-D-arabinofuranosyl)-5-iodouracil. Grades: ≥95%. CAS No. 69123-98-4. Molecular formula: C9H10FIN2O5. Mole weight: 372.09. | |
| Fialuridine | Fialuridine is a nucleoside analog with antiviral activity [1]. Fialuridine shows anti-orthopoxvirus activity [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: FIAU; DRG-0098; NSC 678514. CAS No. 69123-98-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-118122. | |
| Fialuridine 5'-Monophosphate | Fialuridine 5'-Monophosphate (FIAUMP) is the phosphorylated derivative and major metabolite of the antiviral agent Fialuridine. Studies show that purified mammalian DNA polymerases were able to incorporate FIAUMP into the nascent DNA chain during in vitro DNA synthesis. Synonyms: 1-(2-Deoxy-2-fluoro-5-O-phosphono-β-D-arabinofuranosyl)-5-iodo-2,4(1H,3H)-pyrimidinedione. CAS No. 99891-31-3. Molecular formula: C9H11FIN2O8P. Mole weight: 452.07. | |
| Fianlimab | Fianlimab (REGN3767) is a human monoclonal antibody that targets the immune checkpoint receptor LAG-3 on T cells and has anti-tumour activity [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: REGN3767. CAS No. 2126132-98-5. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99617. | |
| Fiber | Our wide distribution network, with locations coast-to-coast, helps guarantee fast, reliable service to Univar's customers. |  |
| Fiberglass Pipe | Fiberglass Pipe. Group: Polymers. |  |
| Fiberglass Rope | Fiberglass Rope. Group: Polymers. | |
| Fibers | Fibers. Group: Polymers. | |
| Fiboflapon | Fiboflapon (GSK2190915; AM-803) is a potent and orally bioavailable 5-lipoxygenase-activating protein ( FLAP ) inhibitor with a potency of 2.9 nM in FLAP binding, an IC 50 of 76 nM for inhibition of LTB4 in human blood [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: GSK2190915; AM-803. CAS No. 936350-00-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg. Product ID: HY-15874. | |
| Fiboflapon sodium | Fiboflapon sodium (GSK2190915; AM-803) is a potent and orally bioavailable 5-lipoxygenase-activating protein ( FLAP ) inhibitor with a potency of 2.9 nM in FLAP binding, an IC 50 of 76 nM for inhibition of LTB4 in human blood [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: GSK2190915 sodium salt; AM-803 sodium. CAS No. 1196070-26-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg. Product ID: HY-15874A. | |
| Fibre board drums | 1ea Pack Size. Group: Equipment. CAS No. Prepack ID 90027294-1ea. See USA prepack pricing. |  |
| Fibrin | Fibrin, isolated from bovine blood, is an insoluble protein produced in response to bleeding. Fibrin is the major component of the blood clot and is used for coagulation [1]. Uses: Scientific research. Group: Natural products. CAS No. 9001-31-4. Pack Sizes: 25 mg; 50 mg; 100 mg. Product ID: HY-B0665. | |
| Fibrin (Bovine) | Fibrinogen has been used in studies of haemostatic therapy in surgical and massive trauma patients. These studies have shown that fibrinogen may prove to be more superior in stopping blood loss when compared to using fresh frozen plasma (FFP). Group: Biochemicals. Alternative Names: Factor I. Grades: Molecular Biology Grade. CAS No. 9001-31-4. Pack Sizes: 1g. US Biological Life Sciences. | Worldwide |
| Fibrin from human plasma | insoluble powder. Group: Fluorescence/luminescence spectroscopy. | |
| Fibrinogen Binding Inhibitor Peptide | Fibrinogen Binding Inhibitor Peptide is an effective inhibitor of the binding of fibrinogen, fibronectin and von Willebrand factor to thrombin- or ADP-stimulated platelets. It is also a synthetic dodecapeptide that represents the specific platelet receptor recognition site for the human fibrinogen G-chain (residues 400-411). Synonyms: H-His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val-OH; L-histidyl-L-histidyl-L-leucyl-glycyl-glycyl-L-alanyl-L-lysyl-L-glutaminyl-L-alanyl-glycyl-L-alpha-aspartyl-L-valine; fibrinogen-γ fragment 400-411. Grades: ≥95%. CAS No. 89105-94-2. Molecular formula: C50H80N18O16. Mole weight: 1189.28. | |
| Fibrinogen Binding Inhibitor Peptide | Fibrinogen Binding Inhibitor Peptide is a dodecapeptide (HHLGGAKQAGDV, H12), which is a fibrinogen γ-chain carboxy-terminal sequence (γ400-411). Fibrinogen Binding Inhibitor Peptide is a specific binding site of the ligand for activated glycoprotein (GP) IIb/IIIa. Uses: Scientific research. Group: Peptides. CAS No. 89105-94-2. Pack Sizes: 5 mg; 10 mg. Product ID: HY-P1507. | |
| Fibrinogen-Binding Peptide | Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen-Binding Peptide binds fibrinogen and inhibits both the adhesion of platelets to fibrinogen and platelet aggregation, and also inhibits the adhesion of platelets to vitronectin [1]. Uses: Scientific research. Group: Peptides. CAS No. 137235-80-4. Pack Sizes: 5 mg; 10 mg. Product ID: HY-P1741. | |
| Fibrinogen-Binding Peptide | Fibrinogen-Binding Peptide (designed by the anti-complementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. It binds to fibrinogen and inhibits platelet adhesion to fibrinogen and platelet aggregation, as well as platelet adhesion to hyalonectin. Synonyms: H-EHIPA-OH; L-alpha-glutamyl-L-histidyl-L-isoleucyl-L-prolyl-L-alanine; N-(1-(N-(N-L-alpha-glutamyl-L-histidyl)-L-isoleucyl)-L-prolyl)-L-Alanine; EHIPA. Grades: ≥95%. CAS No. 137235-80-4. Molecular formula: C25H39N7O8. Mole weight: 565.62. | |
| Fibrinogen-Binding Peptide butyl acetate | Fibrinogen-Binding Peptide (designed by the anti-complementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. It binds to fibrinogen and inhibits platelet adhesion to fibrinogen and platelet aggregation, as well as platelet adhesion to vitronectin. Synonyms: Fibrinogen-Binding Peptide (fb-acetate); H-Glu-His-Ile-Pro-Ala-OH butyl acetate; EHIPA butyl acetate; L-alpha-glutamyl-L-histidyl-L-isoleucyl-L-prolyl-L-alanine butyl acetate. Grades: ≥95%. Molecular formula: C31H51N7O10. Mole weight: 681.80. | |
| Fibrinogen (Bovine) | Fibrinogen (Bovine) is a selective proteolytic molecule that can be activated by thrombin to assemble fibrin clots. Fibrinogen can regulate the activation of NF-KB in endothelial cells and upregulate the expression of inflammatory chemokines MCP-1 and MCP-1. Fibrinogen plays a key role in blood clotting, thrombosis, atherosclerosis and the pathological development of venous grafts, and can be used in the study of blood clotting and vascular diseases [1] [2] [3]. Uses: Scientific research. Group: Biochemical assay reagents. CAS No. 9001-32-5. Pack Sizes: 50 mg; 100 mg. Product ID: HY-125864. | |
| Fibrinogen from bovine plasma | Type I-S, 65-85% protein (?75% of protein is clottable). Group: Fluorescence/luminescence spectroscopy. | |
| Fibrinogen from rat plasma | 60-80% protein (?60% of protein is clottable). Group: Fluorescence/luminescence spectroscopy. | |
| Fibrinopeptide A human | ?96% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Fibrinopeptide A, human | Fibrinopeptide A, human, located at the NH2-termini of the Aα chain, is a short peptide with 16 residues cleaved from fibrinogen by thrombin. Synonyms: Human fibrinopeptide A; H-Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg-OH; L-alanyl-L-alpha-aspartyl-L-seryl-glycyl-L-alpha-glutamyl-glycyl-L-alpha-aspartyl-L-phenylalanyl-L-leucyl-L-alanyl-L-alpha-glutamyl-glycyl-glycyl-glycyl-L-valyl-L-arginine. Grades: ≥95%. CAS No. 25422-31-5. Molecular formula: C63H97N19O26. Mole weight: 1536.56. | |
| Fibrinopeptide A, human TFA | Fibrinopeptide A, human TFA is a 16-residue short polypeptide cleaved from fibrinogen by thrombin. Fibrinopeptide A, human locates at the NH 2 -termini of the Aα chain [1]. Uses: Scientific research. Group: Peptides. Alternative Names: Human fibrinopeptide A TFA. CAS No. 61533-47-9. Pack Sizes: 5 mg; 10 mg. Product ID: HY-P1538A. | |
| Fibrinopeptide B | Synonyms: Fibrinopeptide B, human. Grades: >95%. CAS No. 36204-23-6. Molecular formula: C66H93N19O25. Mole weight: 1552.56. | |
| Fibrinopeptide B human | ?97% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Fibroblast Cell, 3T3/A31 | Cellular protein preparation from murine 3T3 fibroblasts. Group: Biologicals. Grades: Lysate. Pack Sizes: 50ul, 100ul. US Biological Life Sciences. | Worldwide |
| Fibroblast Cell, 3T3 L1 Adipocytes, Control Extract, LIF- | Fibroblast Cell, 3T3 L1 Adipocytes, Control Extract, LIF-. Group: Molecular Biology. Grades: Lysate. Pack Sizes: 80ul. US Biological Life Sciences. | Worldwide |
| Fibroblast Growth Factor | Fibroblast Growth Factors are a family of cell signalling proteins produced by macrophages, consisting of 23 members in humans. They have various functions so that is involved in multiple processes, regulating fundamental developmental pathways. Synonyms: FGF. | |
| Fibroblast Growth Factor-10 human | >97% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture. Group: Fluorescence/luminescence spectroscopy. | |
| Fibroblast Growth Factor-18 human | >95% (SDS-PAGE and HPLC), recombinant, expressed in E. coli, lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| FIBROBLAST GROWTH FACTOR-4 HUMAN RECOMBI | FIBROBLAST GROWTH FACTOR-4 HUMAN RECOMBI. Uses: Designed for use in research and industrial production. Additional or Alternative Names: FIBROBLAST GROWTH FACTOR-4 HUMAN RECOMBI;fibroblast growth factor-4 human*recombinant cell;FIBROBLAST GROWTH FACTOR-4, HUMAN RECOMB INANT, CELL CULTURE TESTED. Product Category: Heterocyclic Organic Compound. CAS No. 123584-45-2. Product ID: ACM123584452. Alfa Chemistry ISO 9001:2015 Certified. | |
| Fibroblast Growth Factor-5 human | recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture, ?97% (SDS-PAGE and N-terminal analysis). Group: Fluorescence/luminescence spectroscopy. | |
| Fibroblast Growth Factor-8b from mouse | >97% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| Fibroblast Growth Factor-9 human | recombinant, expressed in baculovirus infected Sf21 cells, lyophilized powder, suitable for cell culture, ?97% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| Fibroblast Growth Factor-Acidic human | FGF-Acidic, recombinant, expressed in E. coli, suitable for cell culture. Group: Fluorescence/luminescence spectroscopy. | |
| Fibroblast Growth Factor-Basic | Fibroblast Growth Factor-Basic is a growth factor encoded by the FGF2 gene. It is found in basement membranes and sub-endothelial extracellular matrix. FGF2 specifically binds to fibroblast growth factor receptor (FGFR) proteins. Synonyms: hBFGF; FGF-Basic; Basic fibroblast growth factor; bFGF. CAS No. 106096-93-9. | |
Our database is helping our users find suppliers everyday.
